| Your Current Location : Fund Card : Portfolio Classification |
 |
|
|
| |
| PGIM India Healthcare Fund IDCW Payout Direct |
| [Equity: Sectoral] |
|
| |
|
|
| Instruments Breakdown |
| Instruments |
Composition |
| Current Asset |
-0.02 |
| Equity |
97.09 |
| Trep |
2.93 |
|
| |
| Concentration Analysis |
| Top 5 Holdings |
40.57% |
| Top 10 Holdings |
62.47% |
| Top 25 Holdings |
95.31% |
|
|
|
| |
| Sector Analysis |
| Sector/Ratings |
Net Asset(%) |
| Pharma & Biotech |
65.05 |
| Healthcare |
25.13 |
| Chemicals |
3.06 |
| Cash |
2.91 |
| Technology |
1.38 |
| Miscellaneous |
1.17 |
| Retail |
0.75 |
| Software & Services |
0.55 |
|
|
|
|
|
| Portfolio Metrics |
|
| PB Ratio |
7.29 |
| PE Ratio |
50.24 |
|
| |
| Top 25 Holdings |
|
|
| Holdings |
Net Asset(%) |
| Sun Pharmaceutical Industries Limited |
11.77 |
| DIVI LABORATORIES LTD |
10.09 |
| (5) Total outstanding exposure in derivative instruments as on April 30, 2026 is Rs. Nil. |
6.40 |
| J B Chemicals and Pharma Ltd |
6.36 |
| Rubicon Research Limited |
5.95 |
| Max Healthcare Institute Limited |
5.29 |
| Mankind Pharma Limited |
5.12 |
| Ajanta Pharma Limited |
4.66 |
| Krishna Inst of Medical Sciences Ltd. |
3.77 |
| NAVIN FLUORINE INTERNATIONAL L |
3.06 |
| Clearing Corporation of India Ltd. |
2.93 |
| Neuland Laboratories Limited |
2.88 |
| Dr Reddys Laboratories Limited |
2.87 |
| Dr Lal Path Labs Ltd |
2.87 |
| Abbott India Limited |
2.86 |
| Torrent Pharmaceuticals Limited |
2.61 |
| Sai Life Sciences Limited |
2.52 |
| Anthem Biosciences Limited |
2.26 |
| EQ- JUPITER LIFE LINE HOSPITALS LTD |
1.99 |
| EQ- GLOBAL HEALTH LTD. |
1.76 |
| Cipla Limited |
1.58 |
| Fortis Health Care Ltd |
1.51 |
| Lupin Limited |
1.42 |
| Pfizer Limited |
1.40 |
| PB Fintech Limited |
1.38 |
|
|
|
| |
|
| |
| Sector Analysis Graphical Mode |
|
| |
|
|
| |
|
 |
| |
|
|
|
